AVERSIVE THERAPY OF ADDICTIVE DISORDERS: PROBLEMS AND PERSPECTIVES



Cite item

Full Text

Abstract

There was studied the contemporary state of aversive therapy in narcology. Effective disulfiram doses in alcoholic therapy were analyzed. There were given investigation results of effectiveness and safety of cyanamide (COLME) in therapy of alcoholism, including adolescents and women. There were shown perspectives of usage of aversive means during alcoholism in combination with naltrexone and comorbide pathology.

About the authors

Alexey Yurievich Egorov

1) I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Acad. Sci;2) St. Petersburg Medical Academy for Postgraduate Education

Email: draegorov@mail.ru
1) лаборатория нейрофизиологии и патологии поведения; 2) кафедра психиатрии; 1) Учреждение Российской академии наук «Институт эволюционной физиологии и биохимии им. И.М. Сеченова РАН»; 2) Санкт-Петербургская медицинская академия последипломного образования; 1) I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Acad. Sci;2) St. Petersburg Medical Academy for Postgraduate Education

Alexander Genrichovich Sofronov

St. Petersburg Medical Academy for Postgraduate Education

Email: alex-sofronov@yandex.ru
кафедра психиатрии; Санкт-Петербургская медицинская академия последипломного образования; St. Petersburg Medical Academy for Postgraduate Education

References

  1. Алкоголизм: Руководство для врачей [Под ред. Г.В. Мо-розова, В.Е. Рожнова, Э.А. Бабаяна]. - М.: Медицина, 1983.
  2. Валентик, Ю.В. Отчет об ограниченных клинических испытаниях препарата Kolme (Cyanamid) / Ю.В. Валентик, В.П. Лисенко. - М., 1999.
  3. Валентик, Ю.В. Применение препарата Колме при лечении больных алкоголизмом / Ю.В. Валентик, Е.М. Но-виков // Наркология. - 2002. - № 3. - C. 32-37.
  4. Иванец, Н.Н. Результаты клинико-катамнестического сравнительного исследования препарата Колме в терапии алкогольной зависимости / Н.Н. Иванец, М.А. Винникова, А.В. Козырева // Вопр. наркол. - 2006. - № 2. - С. 21-29.
  5. Руководство по наркологии [Под ред. Н.Н. Иванца]. - М.: Медпрактика-М, 2002. - Т. 1. - 444 с.
  6. Собетов, Б.Г. Naltetlong - инъекционная пролонгированная форма «2 в 1» дисульфирама и налтрексона для лечения алкогольной и наркотической зависимостей. Результаты доклинических исследований / Б.Г. Собетов, Е.В. Шияненко, Н.Л. Заярнюк и др. // Наркология. - 2009. - № 7. - С. 25-28.
  7. Софронов, А.Г. Исследование сравнительной эффективности Колме и дисульфирама при лечении хронического алкоголизма у женщин / А.Г. Софронов, А.Ю. Егоров // Психиатр. и психофармакотерапия. - 2009. - Т. 11, № 1. - С. 45-49.
  8. Abajo, P. Eczematous erythroderma induced by cyanamide / P. Abajo, C. Feal, T. Sanz-Sanchez et al. // Contact Der matitis. - 1999. - Vol. 40. - P. 160-161.
  9. Ajima, M. Cyanamide-induced granulocytopenia / M. Ajima, K. Usuki, A. Igarashi et al. // Internal Medicine. - 1997. - Vol. 36. - P. 640-642.
  10. Allen, J.P. Techniques to enhance compliance with disulfiram / J.P. Allen, R.Z. Litten // Alcoholism: Clinical and Experimental Research. - 1992. - Vol.16. - P. 1035-1041.
  11. Annis, H.M. The use of calcium carbimide in relapse prevention counselling: results of a randomized controlled trial / H.M. Annis, J.E. Peachey // British Journal of Addiction. - 1992. - Vol. 87. - Р. 63-72.
  12. Azrin, N.H. Alcoholism treatment by disulfiram and community reinforcement therapy / N. H. Azrin, R.W. Sisson, R. Meyers, M. Godley // J. Behav. Ther. Exp. Psychiatry. -1982. - Vol. 13, № 2. - P.105-112.
  13. Barth, K.S. Disulfiram: an old therapeutic with new applications / K. S. Barth, R. J. Malcolm // CNS Neurol Disord Drug Targets. - 2010. - Vol. 9, № 1. - P. 5-12.
  14. Bergstrom, B. Is disulfiram implantation effective? / B. Bergstrom, H. Ohlin, P.E. Lindblom, J. Wadstein // Lancet. - 1982. - P. 49-50.
  15. Brewer, C. How effective is the standard dose of disulfiram? A review of the alcohol - disulfiram reaction in practice// British J. of Psychiatry. - 1984. - Vol. 144. - P. 200-202.
  16. Bruguera, M. Cyanamide hepatotoxicity. Incidence and clinico-pathological features / M. Bruguera, A. Pares, D. Heredia, J. Rodes // Liver. - 1987. - Vol. 7. - P. 216-222.
  17. Brust, J.C.M. Neurological aspects of substance abuse. - 2-nd Ed. - Philadelphia, Elsevier Inc., 2004.
  18. Ferguson, J.K.W. A new drug for the treatment of alcoholism // Canad. M. A. J. - 1956. - Vol. 74. - P. 793-795.
  19. Fuller, R.K. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study / R. K. Fuller, L. Branchey, D.R. Brightwell et al. // JAMA. - 1986. - Vol. 256, № 11. - P. 1449-1455.
  20. Gaval-Cruz, M. Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures / M. Gaval-Cruz, J.P. Schroeder, L.C. Liles et al. // Pharmacol Biochem Behav. - 2008. - Vol. 89, № 4. - P. 556-562.
  21. Kranzler, H.R. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research // Alcohol and Alcoholism. - 2000. - Vol. 35, № 6. - P. 537-547.
  22. Kawana, S. Drug eruption induced by cyanamide (carbimide): a clinical and histopathologic study of 7 patients // Dermatology. - 1997. - Vol. 195. - P. 30-34.
  23. Kristenson, H. How to get the best out of antabuse// Alcohol and Alcoholism. - 1995. - № 11. - P. 775-783.
  24. Malcolm, R. The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice / R. Malcolm, M.F. Olive, W. Lechner // Expert Opin Drug Saf. - 2008. - Vol. 7, № 4. - P. 459-472.
  25. Mutschler, J. Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action / J. Mutschler, A. Diehl, F. Kiefer // J. Clin. Psychopharmacol. - 2009. - Vol. 29, № 1. - P. 99-101.
  26. Mutschler, J. Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder-a case series / J. Mutschler, M. Grosshans, A. Koopmann et al. // Alcohol Alcohol. - 2010. - Vol. 45, № 2. - P. 146-150.
  27. Niederhofer, H. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents / H. Niederhofer, W. Staffen // Drug. Alcohol Rev. - 2003. - Vol. 22, № 3. - P. 295-297.
  28. Niederhofer, H. Comparison of cyanamide and placebo in the treatment of alcohol dependence in adolescents / H. Niederhofer, W. Staffen, A. Mair // Alcohol and Alcoholism. - 2003. - Vol. 38, № 1. - P. 50-53.
  29. Peachey, J.E. Calcium carbimide in alcoholism treatment. Part 1: A placebo-controlled, double-blind clinical trial of short-term efficacy / J.E. Peachey, H.M. Annis, E.R. Bornstein et al. // British J. of Addiction. - 1989. - Vol. 84. - P. 877-887.
  30. Peachey, J.E. Calcium carbimide in alcoholism treatment. Part 2: Medical findings of a short-term, placebo-controlled, double-blind clinical trial / J. E. Peachey, H.M. Annis, E.R. Bornstein et al. // Brit. J. Addict. - 1989. - Vol. 84. - P. 1359-1366.
  31. Petrakis, I.L. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders / I.L. Petrakis, J. Poling, C. Levinson et al. // Biol. Psychiatry. - 2005. - Vol. 57, № 10. - P. 1128-1137.
  32. Petrakis, I.L. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder / I.L. Petrakis, J. Poling, C. Levinson et al. // Biol. Psychiatry. - 2006. - Vol. 60, № 7. - P. 777-783.
  33. Petrakis, I.L. Naltrexone and disulfiram in patients with alcohol dependence and current depression / I.L. Petrakis, E. Ralevski, C. Nich et al. // J. Clin. Psychopharmacol. - 2007. - Vol. 27, № 2. - P.160-165.
  34. Rios-Herranz, E. Aplastic anemia and cyanamide / E. Rios-Herranz, V. Carrasco-Baraja, D. Lopez-Lacomba, J.L. Diez-Martin // European J. of Haematology. - 1992. - Vol. 48. - P. 182-197.
  35. Suh, J.J. The status of disulfiram: a half of a century later / J.J. Suh, H.M. Pettinati, K.M. Kampman, C.P. O'Brien // J. Clin. Psychopharmacol. - 2006. - Vol. 26, № 3. - P. 290-302.
  36. Suzuki, Y. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases / Y. Suzuki, A. Yokoyama, M. Nakano et al. // Alcoholism: Clinical and Experimental Research. - 2000. - Vol. 24. - P. 100S-105S.
  37. Tamai, H. Comparison of cyanamide and disulfiram in effects on liver function / H. Tamai, A. Yokoyama, K. Okuyama et al. // Alcoholism: Clinical and Experimental Research. - 2000. - Vol. 24. - P. 97S-99S.
  38. Torrelo, A. Lichen planus-like eruption with esophageal involvement as a result of cyanamide / A. Torrelo, C. Soria, A. Rocamora // J. of the American Academy of Dermatology. - 1990. - Vol. 23. - P. 1168-1169.
  39. Trйbol, I. Allergic contact dermatitis from cyanamide / I. Trйbol, O. Lasa, B. Navajas et al. // Dermatitis. - 2005. - Vol. 16, № 1. - P. 32-33.
  40. Verge, C. Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: Is there still a role for these drugs? / C. Verge, M.I. Lucena, E. Lуpez-Torres et al. // World J. Gastroenterol. - 2006. - Vol. 12, 31. - P. 5078-5080.
  41. Wilson, A. Medications for Treating Alcohol Dependence // Am. Fam. Physician. - 2005. - Vol. 72, № 9. - P. 1775-1780.
  42. Wilson, A. Disulfiram implantation: A trial using placebo implants and two types of controls / A. Wilson, W.J. Davidson, R. Blanchard // J. of Studies on Alcohol. - 1980. - Vol. 41. - P. 429-436.
  43. Yerro, C.P. Relapsing pancytopenia following exposure and re-exposure to cyanamide / C. P. Yerro, C.P. Lopez, A.R. Bernardino et al. // European J. of Haematology. - 2000. - Vol. 65. - P. 414-415.
  44. Yokoyama, A. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation / A. Yokoyama, S. Sato, K. Maruyama et al. // Alcoholism. Clinical and Experimental Research. - 1995. - Vol. 19. - P. 1307-1311.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Egorov A.Y., Sofronov A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies